Navigation Links
Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer
Date:1/30/2009

DALLAS, Jan. 30 /PRNewswire-USNewswire/ -- Officials with Baylor Health Care System announced today that Bernard Brigonnet will join the Baylor Research Institute (BRI) as vice president and chief operating officer, effective Feb. 1.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090130/DC65143)

Under his leadership, the institute will further pursue the development of its unique research technologies in areas such as immunology, transplantation, metabolic disease, cardiovascular disease and colon cancer, to name a few.

In addition, Brigonnet will oversee the institute's more than $40 million a year budget which has grown in just ten short years to become a major clinical research program.

"Baylor is increasingly becoming a leader in medical research and we hope to license our advanced technologies in the marketplace to reach even more patients who need them," says Michael Ramsay, M.D., president, Baylor Research Institute. "Mr. Brigonnet has a tremendous vision of where BRI can take the Baylor Health Care System and we are very excited to have someone of his caliber take us to the next level."

A native of France, Brigonnet has more than 30 years of experience in the biotechnology and pharmaceutical industries where he has served in a senior leadership capacity for a number of international organizations.

Most recently as CEO of Medicen Paris Region, he helped create one of the largest collaborations of research institutes, pharmaceutical and biotechnology companies as well as public and private universities following an initiative by the French government to support world-competitive clusters for innovation in life sciences. Prior to that, he served as president and CEO of Serono France S.A., a leader in the development and manufacturing of biopharmaceutical treatments.

As executive vice president and chief operating officer of Immuno-Designed Molecules S.A., he negotiated one of the largest partnerships with a global pharmaceutical company in Europe and subsequently opened the company's headquarters in the U.S.

He also has held executive positions with internationally-known pharmaceutical companies such as Bristol-Myers-Squibb and Merck & Co., Inc. Because of his expertise in these industries, Brigonnet has been recently called on to negotiate strategic alliances between other international corporations in the U.S. and Europe.

"BRI is currently pursuing partnerships with international companies in these industries and because of Bernard's extensive experience in this arena, he will be leading these negotiations," adds Dr. Ramsay. "Our goal is to accelerate this advanced science so that it is available to all who need it and Mr. Brigonnet will help us achieve that."

Additionally, Brigonnet will partner with the Baylor Health Care System Foundation to facilitate the development of more philanthropic support for research at Baylor.

Dallas-based Baylor Research Institute, an affiliate of Baylor Health Care System, promotes research bringing innovative treatments from the laboratory to the patient bedside. The Institute focuses on basic and translational science, clinical trials, health care effectiveness and quality of care research. Currently, investigators at Baylor are conducting 800 active research protocols spanning more than 20 medical specialties. Opened in 1996, Baylor Institute for Immunology Research, a component of BRI, focuses on developing new therapies to treat conditions that involve the immune system, such as cancer, autoimmune diseases, infectious diseases and organ transplantation.

For more information about the Baylor Research Institute visit www.BaylorHealth.com.


'/>"/>
SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
2. Home Oxygen Community Applauds Senator Bernard Sanders for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
3. Bernard A. Krooks From the Special Needs Alliance to Talk Tax Strategies for Individuals With Disabilities Tomorrow on Good Morning America NOW
4. Vikings Wide Receiver Bernard Berrian Pledges Up to $10,000 to Second Harvest Heartland; Challenges the Community and Fellow Vikings to Help Feed the Hungry This Holiday Season
5. Zimmer Holdings Names Betsy Bernard to Board of Directors
6. Richard Greco Joins Mediware Board
7. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
8. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
9. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
10. Nick Childs Joins Grey New York as Director of Content Development
11. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: